08-Aug-2022 | Facts and Factors
According to Facts and Factors, the global gene synthesis market size was worth USD 1,528.10 million in 2021 and is estimated to grow to USD 4,021.41 million by 2028, with a compound annual growth rate (CAGR) of approximately 17.50% over the forecast period. The report analyzes the gene synthesis market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the gene synthesis market.
Gene synthesis is a synthetic biology process used in the manufacturing or development of artificial genes in a lab setting. Molecular cloning, high-throughput protein expression, and the development of fusion proteins all use gene synthesis techniques. Molecular cloning techniques have historically been used but are expensive and time-consuming. The rise in investment in gene synthesis is one of the main factors projected to fuel the growth of the worldwide market for gene synthesis. The shortage of highly qualified employees and drawn-out approval procedures may impede market expansion throughout the projection period. However, developments that might propel the global gene synthesis market include the rising use of gene synthesis in creating customized medicine.
Browse the full “Gene Synthesis Market Size, Share, Growth Analysis Report By Method (Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis), By Service (Antibody DNA Synthesis, Viral DNA Synthesis, Others), By Application (Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis, Others), By End-user (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028" report at https://www.fnfresearch.com/gene-synthesis-market
It is projected that over the next few years, demand in the gene synthesis market will be driven by a greater emphasis on clinical research to uncover biological systems at the fundamental molecular level. The growth of life science research is a result of recent technical developments that have produced well-designed goods and services, including molecular separation, gene synthesis on microchips, and protein purification.
Segmental Overview
The global gene synthesis market is segregated based on method, service, application, end-user, and region. Based on the method, the market is segmented into solid-phase synthesis, chip-based synthesis, and PCR-based enzyme synthesis. Among these, solid-phase synthesis dominated the market in 2021. Based on Service, the market is classified into antibody DNA synthesis, viral DNA synthesis, and others. In 2021, the market was dominated by the DNA synthesis sector. Based on application, the market is classified into gene & cell therapy development, vaccine development, disease diagnosis, and others. Among these, gene & cell therapy dominated the market in 2021. Based on end-use, the market is segmented into biotechnology & pharmaceutical companies, academic & government research institutes, and contract research organizations. The Academic & government research institutions segment dominated the market in 2021.
Regional Overview
In 2021, North America dominated the market for gene synthesis, and it is anticipated that this dominance will persist in the years to come. The United States has the greatest market share in the North American area due to the presence of major industry players. The main drivers of the enormous market are the incidence of genetic and chronic diseases like cancer, as well as the aging population, rising demand for targeted and customized medication, and government programs that encourage gene synthesis. However, because of growing investment from governmental and corporate institutions, Asia Pacific is projected to develop into a lucrative market in the near future.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 1,528.10 Million |
Projected Market Size in 2028 |
USD 4,021.41 Million |
CAGR Growth Rate |
17.50% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2028 |
Key Market Players |
GenScript, GENEWIZ, Boster Biological Technology, Twist Bioscience, ProteoGenix, Biomatik, ProMab Biotechnologies Inc., Thermo Fisher Scientific Inc., Integrated DNA Technologies Inc., OriGene Technologies Inc., and Others |
Key Segment |
By Method, Service, Application, End User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Competitive Landscape
The report contains qualitative and quantitative research on the global gene synthesis market, as well as detailed insights and development strategies employed by the leading competitors. The report also provides an in-depth analysis of the market's main competitors, as well as information on their competitiveness. The research also identifies and analyses important business strategies used by these main market players, such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts.
Key players functioning in the global gene synthesis market include GenScript; GENEWIZ; Boster Biological Technology; Twist Bioscience; ProteoGenix; Biomatik; ProMab Biotechnologies, Inc.; Thermo Fisher Scientific, Inc.; Integrated DNA Technologies, Inc.; OriGene Technologies, Inc.
Recent Development:
- March 2021: Aldevron increased the size of its Madison production site. The business is expanding the production of novel medicines and goods involving gene synthesis at this new facility. The company's product manufacture has increased as a result of this expansion, and the project scope and scale have also increased.
The global gene synthesis market is segmented as follows:
By Method
- Solid-phase Synthesis
- Chip-based Synthesis
- PCR-based Enzyme Synthesis
By Service
- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
By Application
- Gene & Cell Therapy Development
- Vaccine Development
- Disease Diagnosis
- Others
By End User
- Biotechnology & Pharmaceutical Companies
- Academic & Government Research Institutes
- Contract Research Organizations
By Region
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
